Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy.
Shima M, Suzuki N, Nishikii H, Amano K, Ogawa Y, Kobayashi R, Ozaki R, Yoneyama K, Mizuno N, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Seki Y, Nogami K. Shima M, et al. Among authors: ozaki r. Thromb Haemost. 2024 Sep 12. doi: 10.1055/a-2384-3585. Online ahead of print. Thromb Haemost. 2024. PMID: 39134043 Free article.
A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.
Shima M, Amano K, Ogawa Y, Yoneyama K, Ozaki R, Kobayashi R, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Suzuki N, Seki Y, Nogami K. Shima M, et al. Among authors: ozaki r. J Thromb Haemost. 2023 Mar;21(3):534-545. doi: 10.1016/j.jtha.2022.10.004. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696195 Free article. Clinical Trial.
Temporal incremental healthcare costs associated with complications in Hong Kong Chinese patients with type 2 diabetes: A prospective study in Joint Asia diabetes evaluation (JADE) Register (2007-2019).
Lui JNM, Lau ESH, Li AQY, Zhang Y, Lim LL, Chun-KwunO, Wong KTC, Yang A, Wu H, Ma RCW, Kong APS, Ozaki R, Luk AOY, Chow EYK, Chan JCN. Lui JNM, et al. Among authors: ozaki r. Diabetes Res Clin Pract. 2024 Dec 17;219:111961. doi: 10.1016/j.diabres.2024.111961. Online ahead of print. Diabetes Res Clin Pract. 2024. PMID: 39701541
Hypoxia-inducible factor-targeting therapy augmented the sensitivity to programmed death ligand-1 blockade by enhancing interferon-γ-induced chemokines in tumor cells.
Yabuki Y, Mitsuhashi A, Ogino H, Yoshida A, Nguyen NT, Yoneda H, Ozaki R, Tsukazaki Y, Morita Y, Nokihara H, Sato S, Shinohara T, Hanibuchi M, Nishioka Y. Yabuki Y, et al. Among authors: ozaki r. Int J Cancer. 2024 Dec 17. doi: 10.1002/ijc.35301. Online ahead of print. Int J Cancer. 2024. PMID: 39686841
Impact of CT-angiography derived plaque characteristics on cardiac events in patients with a negative invasive fractional flow reserve.
Ozaki R, Motoyama S, Ozaki Y, Sarai M, Kawai H, Ismail TF, Fujiwara W, Miyajima K, Nagahara Y, Uchida N, Garg S, Kawashima N, Niwa Y, Takatsu H, Yoshiki Y, Ohta M, Muramatsu T, Harada M, Naruse H, Matsui A, Kamiya H, Tobe A, Tsung-Ying T, Bando Y, Onuma Y, Takahashi H, Izawa H, Serruys PW, Murohara T. Ozaki R, et al. Int J Cardiol. 2024 Dec 8;421:132895. doi: 10.1016/j.ijcard.2024.132895. Online ahead of print. Int J Cardiol. 2024. PMID: 39657856 Free article.
270 results